Literature DB >> 3742877

Small and large forms of hepatitis B e antigen in the serum: determination by two-site sandwich radioimmunoassay with monoclonal antibodies.

K Baba, I Ise, S Aihara, S Kishimoto, F Tsuda, K Tachibana, Y Miyakawa, M Mayumi.   

Abstract

Serum samples containing hepatitis B e antigen (HBeAg) were subjected to electrophoresis in agarose, and fast-migrating 'small' HBeAg and slow-migrating 'large' IgG-associated HBeAg were pooled separately. HBeAg of each category was determined by a two-site radioimmunoassay that sandwiched HBeAg between monoclonal antibody (anti-HBe) against one epitope of HBeAg, fixed on a solid support, and anti-HBe against another epitope, labelled with radioiodine. Eighteen sera in which small HBeAg dominated revealed activities of hepatitis B surface antigen-associated DNA polymerase significantly higher than 14 sera in which large HBeAg dominated (logarithm of ct/min, mean +/- s.e. 3.36 +/- 0.08 versus 2.14 +/- 0.11, P less than 0.01). Shift from small HBeAg to large HBeAg was observed, along with the disappearance of DNA polymerase, in the serum from two carriers who seroconverted to anti-HBe.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742877      PMCID: PMC1542356     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants.

Authors:  K Okada; I Kamiyama; M Inomata; M Imai; Y Miyakawa
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

3.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

4.  Hepatitis B core antigen. Detection of antibody by radioimmunoprecipitation.

Authors:  Y Moritsugu; J W Gold; J Wagner; R Y Dodd; R H Purcell
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

5.  Hemagglutination assay for antigen and antibody associated with viral hepatitis.

Authors:  G N Vyas; N R Shulman
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

6.  Chemical coupling of proteins to agarose.

Authors:  J Porath; R Axen; S Ernback
Journal:  Nature       Date:  1967-09-30       Impact factor: 49.962

7.  A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg.

Authors:  M Imai; Y Yanase; T Nojiri; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

8.  Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.

Authors:  H J Alter; L B Seeff; P M Kaplan; V J McAuliffe; E C Wright; J L Gerin; R H Purcell; P V Holland; H J Zimmerman
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

9.  DNA polymerase associated with human hepatitis B antigen.

Authors:  P M Kaplan; R L Greenman; J L Gerin; R H Purcell; W S Robinson
Journal:  J Virol       Date:  1973-11       Impact factor: 5.103

10.  Duality of hepatitis B e antigen in serum of persons infected with hepatitis B virus: evidence for the nonidentity of e antigen with immunoglobulins.

Authors:  K Takahashi; M Imai; Y Miyakawa; S Iwakiri; M Mayumi
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

View more
  3 in total

1.  An investigation on rheumatoid factor of different immunoglobulin classes in hepatitis B virus carriers.

Authors:  K Watanabe; Y Ohkubo; Y Funahashi; T Nishimaki; T Moritoh; R Kasukawa; S Kaise; T Tomita; A Matsukawa
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

2.  Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr.

Authors:  H Okamoto; M Imai; F Tsuda; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  Protein composition of the hepatitis B virus e antigen in the natural course of disease and following interferon therapy.

Authors:  M L Campillo; J A Quiroga; J Bartolomé; G Moraleda; I Castillo; V Carreño
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.